EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Embedded CRISPRi Enhances Gene‐Silencing Efficiency in Drosophila

Pengchong Fu, Xuedi Zhang, Ying Zhou, Jie Zheng, Angyang Sun, Kailong Zhuang, Weiwei Bao, Guanjun Gao iD

Advanced Science · 2026-06 · 13 (31)

DOI: 10.1002/advs.202515849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.03.2026. Verfasst von Pengchong Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: Drosophila melanogaster, CRISPR-Cas Systems, Gene Silencing, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, priority academic program development of jiangsu higher education institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR interference (CRISPRi), leveraging catalytically inactive Cas9 (dCas9), has transformed transcriptional silencing. However, its application in Drosophila melanogaster has been constrained by inconsistent efficiency and limited repression amplitude. Here, we present embedded CRISPR interference (emCRISPRi), an advanced gene‐silencing platform that integrates transcriptional repression domains (Mxi and TRD) into a structurally flexible region of dCas9. This design significantly enhances silencing efficiency, enabling robust repression of coding genes and cis‐regulatory elements, particularly at transcription start site (TSS)‐proximal regions. emCRISPRi demonstrates improved gene‐silencing activity compared to RNA interference (RNAi) at several tested loci and facilitates strong phenotypic rescue via unmodified cDNA. Its versatility is demonstrated through the dissection of Hippo pathway interactions and the mitigation of TDP‐43‐induced neurotoxicity in an amyotrophic lateral sclerosis (ALS) model. These findings position emCRISPRi as a transformative tool for functional genomics, enhancer studies, and disease modeling in Drosophila , with significant potential for cross‐species adaptation and therapeutic innovation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drosophila melanogasterCRISPR-Cas SystemsGene SilencingAmyotrophic Lateral SclerosisAnimalsDrosophila ProteinsRNA InterferenceDisease Models, Animal

Stichwörter der Autor:innen

CRISPRidCas9drosophilatranscriptional repression

Substanzen

Drosophila Proteins

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu Province, China.
  • Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai, China.

ORCID-Profile: Guanjun Gao

Förderung

  • National Natural Science Foundation of China
  • priority academic program development of jiangsu higher education institutions

Zitieren

APA

Fu, P., Zhang, X., Zhou, Y., Zheng, J., Sun, A., Zhuang, K., Bao, W., & Gao, G. (2026). Embedded CRISPRi Enhances Gene‐Silencing Efficiency in Drosophila. Advanced Science, 13(31). https://doi.org/10.1002/advs.202515849

Vancouver

Fu P, Zhang X, Zhou Y, Zheng J, Sun A, Zhuang K, et al. Embedded CRISPRi Enhances Gene‐Silencing Efficiency in Drosophila. Advanced Science. 2026;13(31). doi:10.1002/advs.202515849

BibTeX
@article{Fu2026,
  author = {Fu, Pengchong and Zhang, Xuedi and Zhou, Ying and Zheng, Jie and Sun, Angyang and Zhuang, Kailong and Bao, Weiwei and Gao, Guanjun},
  title = {Embedded CRISPRi Enhances Gene‐Silencing Efficiency in Drosophila},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {31},
  doi = {10.1002/advs.202515849}
}
Kostenlos starten →